WallStSmart

Concord Medical Services Holdings (CCM)vsDaVita HealthCare Partners Inc (DVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 2942% more annual revenue ($14.01B vs $460.51M). DVA leads profitability with a 6.0% profit margin vs -20.2%. DVA appears more attractively valued with a PEG of 0.45. DVA earns a higher WallStSmart Score of 70/100 (B).

CCM

Hold

43

out of 100

Grade: D

Growth: 5.3Profit: 2.0Value: 7.7Quality: 5.5
Piotroski: 6/9Altman Z: -0.95

DVA

Strong Buy

70

out of 100

Grade: B

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCMUndervalued (+67.5%)

Margin of Safety

+67.5%

Fair Value

$11.77

Current Price

$3.97

$7.80 discount

UndervaluedFair: $11.77Overvalued
DVAOvervalued (-13.0%)

Margin of Safety

-13.0%

Fair Value

$127.66

Current Price

$181.55

$53.89 premium

UndervaluedFair: $127.66Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCM3 strengths · Avg: 9.3/10
Revenue GrowthGrowth
57.4%10/10

Revenue surging 57.4% year-over-year

Debt/EquityHealth
-1.7310/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.578/10

Growing faster than its price suggests

DVA5 strengths · Avg: 9.6/10
PEG RatioValuation
0.4510/10

Growing faster than its price suggests

Return on EquityProfitability
81.0%10/10

Every $100 of equity generates 81 in profit

EPS GrowthGrowth
55.8%10/10

Earnings expanding 55.8% YoY

Debt/EquityHealth
-14.0910/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Areas to Watch

CCM4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$17.24M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-21.9%2/10

ROE of -21.9% — below average capital efficiency

Altman Z-ScoreHealth
-0.952/10

Distress zone — elevated risk

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
6.0%3/10

6.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CCM

The strongest argument for CCM centers on Revenue Growth, Debt/Equity, PEG Ratio. Revenue growth of 57.4% demonstrates continued momentum. PEG of 0.57 suggests the stock is reasonably priced for its growth.

Bull Case : DVA

The strongest argument for DVA centers on PEG Ratio, Return on Equity, EPS Growth. PEG of 0.45 suggests the stock is reasonably priced for its growth.

Bear Case : CCM

The primary concerns for CCM are EPS Growth, Market Cap, Return on Equity.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

CCM profiles as a hypergrowth stock while DVA is a value play — different risk/reward profiles.

DVA carries more volatility with a beta of 0.83 — expect wider price swings.

CCM is growing revenue faster at 57.4% — sustainability is the question.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DVA scores higher overall (70/100 vs 43/100). CCM offers better value entry with a 67.5% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Concord Medical Services Holdings

HEALTHCARE · MEDICAL CARE FACILITIES · China

Concord Medical Services Holdings Limited, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Visit Website →

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

Want to dig deeper into these stocks?